Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BBNX), a pioneering leader in the development of advanced ...
Beta Bionics stock opens 29% higher in Nasdaq debut
Thursday marked the Nasdaq Global Market debut of Beta Bionics, Inc. as its initial public offering (IPO) opened for trading ...
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the ...